InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by McKhann Chas, Chairman & CEO. Insider active across 3 companies, notably Apollo Endosurgery, Inc.. Cumulatively, 8 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €297k. History available since 18 August 2021. The latest transaction was disclosed on 1 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to McKhann Chas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
722,396 sharesCommon StockSEC:0001140361-24-041406:0
110,313 shares0Common StockSEC:0001593968-24-000432:0
612,083 shares0Common StockSEC:0001593968-23-001398:0
689,880 sharesCommon StockSEC:0001251769-23-000027:0
112,607 shares0Common StockSEC:0001251769-22-000053:0
66,553 shares@ US$5.4269.8% of flowCommon StockSEC:0001251769-22-000036:0
21,156 shares@ US$8.2115.9% of flowCommon StockSEC:0001251769-21-000107:0
21,156 shares@ US$8.2130.2% of flowCommon StockSEC:0001251769-21-000105:0
8 of 8 declarations
About McKhann Chas
McKhann Chas is President and CEO and has filed 8 forms in total. Across the 8 most recent filings, reported sales total EUR 296824, covering the period from 2021-08-20 to 2024-09-18, and the modal transaction nature is Attribution. The filings concern Apollo Endosurgery, Inc. and Silk Road Medical Inc.
